Company Filing History:
Years Active: 2013-2018
Title: The Innovative Contributions of Marcus Branschädel
Introduction
Marcus Branschädel, an accomplished inventor based in Heidelberg, Germany, has made significant strides in the field of biotechnology. With a total of five patents to his name, Branschädel’s work primarily revolves around fusion proteins and their applications in therapeutic, diagnostic, and research contexts.
Latest Patents
One of Branschädel's latest patents is focused on GITRL-collectin fusion proteins and encoding nucleic acids. This invention presents a fusion protein comprising a TNF-superfamily (TNFSF) cytokine or a receptor-binding domain fused to a collectin trimerization domain. It includes a nucleic acid molecule encoding the fusion protein and a cell that houses the nucleic acid molecule. The fusion protein can exist as a trimeric complex or as an oligomer, making it suitable for pharmaceutical compositions as well as therapeutic and diagnostic applications.
Another noteworthy invention involves CD40L collectin fusion proteins and corresponding encoding nucleic acid molecules. Similar to the previous patent, this invention encompasses a fusion protein featuring TNFSF cytokines or receptor binding domains fused to a collectin trimerization domain. The potential for therapeutic, diagnostic, and research applications further underscores the importance of this innovation.
Career Highlights
Branschädel has been associated with notable biotech companies such as Apogenix GmbH and Apogenix AG. His experiences in these organizations have undoubtedly contributed to his extensive knowledge and innovative capabilities within the field.
Collaborations
In the course of his career, Marcus Branschädel has collaborated with distinguished professionals, including Oliver Hill and Christian Gieffers. These partnerships have played a vital role in advancing his research and technological innovations.
Conclusion
Marcus Branschädel's contributions to biotechnology through his patents reflect a deep understanding of molecular biology and its applications in medicine. His innovative work is paving the way for breakthroughs in therapeutic and diagnostic solutions, demonstrating his commitment to advancing the field.